The "Obesity Paradox": Does It Persist Among Israeli Patients With Decompensated Heart Failure? A Subanalysis of the Heart Failure Survey in Israel (HFSIS)

被引:14
作者
Schwartzenberg, Shmuel [1 ]
Benderly, Michal [2 ]
Malnick, Stephen [1 ]
George, Jacob [1 ]
Goland, Sorel [1 ]
机构
[1] Kaplan Med Ctr, Inst Heart, IL-76100 Rehovot, Israel
[2] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Res Policy, Cardiovasc Epidemiol Unit, Ramat Gan, Israel
关键词
Obesity paradox; reverse epidemiology; congestive heart failure; BODY-MASS INDEX; SYSTOLIC BLOOD-PRESSURE; REVERSE EPIDEMIOLOGY; RISK-FACTOR; MORTALITY; PROGNOSIS; SURVIVAL; MANAGEMENT; OUTCOMES;
D O I
10.1016/j.cardfail.2011.09.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Earlier studies among heart failure (HF) patients reported a paradox of reduced mortality rates in those with increased body mass index (BMI). Recently, however, it has been shown that obesity was not associated with better prognosis in certain groups. The aim of this study was to evaluate the "obesity paradox" among patients included in the Heart Failure Survey in Israel (HFSIS). Methods and Results: Clinical, demographic, and laboratory characteristics of 2,323 patients hospitalized with a diagnosis of acute or decompensated chronic HF in 25 public Israeli hospitals between March 1 and April 30, 2003, were categorized by BMI as: normal weight (18.5-24.9 kg/m(2); n = 837), overweight (25.0-29.9 kg/m(2); n = 877), or obese (>= 30.0 kg/m(2); n = 574), excluding 35 patients with BMI <18.5 kg/m(2). Survival over 15 months was inversely related to BMI category. Age-adjusted mortality hazard ratio (HR) was 0.95 (95% confidence interval [CI] 0.79-1.14) for overweight patients and 0.70 (95% CI 0.55-0.88) for obese patients compared with normal-weight patients. After further adjustment for gender, ejection fraction, New York Heart Association functional class, ischemic heart disease, diabetes, hypertension, dyslipidemia, renal function, and medications (angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, beta-blocker, spironolactone), obesity was associated with a nonsignificant HR of 0.79 (95% CI 0.59-1.05). Hypertension and dyslipidemia were also paradoxically associated with better survival in our model (HR 0.74, CI 0.59-0.92; and HR 0.77, CI 0.63-0.94; respectively; both P < .05). Conclusions: Our study falls in line with the obesity paradox observation (in obese but not overweight patients) in a large survey of HF patients, although this finding was not statistically significant on multivariate adjustment analysis. (J Cardiac Fail 2012;18:62-67)
引用
收藏
页码:62 / 67
页数:6
相关论文
共 32 条
[1]   Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study [J].
Adamopoulos, Chris ;
Meyer, Philippe ;
Desai, Ravi V. ;
Karatzidou, Kyparissi ;
Ovalle, Fernando ;
White, Michel ;
Aban, Inmaculada ;
Love, Thomas E. ;
Deedwania, Prakash ;
Anker, Stefan D. ;
Ahmed, Ali .
EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (02) :200-206
[2]   Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome [J].
Alpert, MA .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2001, 321 (04) :225-236
[3]   Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study [J].
Anker, SD ;
Negassa, A ;
Coats, AJS ;
Afzal, R ;
Poole-Wilson, PA ;
Cohn, JN ;
Yusuf, S .
LANCET, 2003, 361 (9363) :1077-1083
[4]   Wasting as independent risk factor for mortality in chronic heart failure [J].
Anker, SD ;
Ponikowski, P ;
Varney, S ;
Chua, TP ;
Clark, AL ;
WebbPeploe, KM ;
Harrington, D ;
Kox, WJ ;
PooleWilson, PA ;
Coats, AJS .
LANCET, 1997, 349 (9058) :1050-1053
[5]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[6]   Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial [J].
Cicoira, Mariantonietta ;
Maggioni, Aldo Pietro ;
Latini, Roberto ;
Barlera, Simona ;
Carretta, Elisa ;
Janosi, Andras ;
Soler Soler, Jordi ;
Anand, Inder ;
Cohn, Jay N. .
EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (04) :397-402
[7]   Waist Circumference, Body Mass Index, and Survival in Systolic Heart Failure: The Obesity Paradox Revisited [J].
Clark, Adrienne L. ;
Fonarow, Gregg C. ;
Horwich, Tamara B. .
JOURNAL OF CARDIAC FAILURE, 2011, 17 (05) :374-380
[8]   The obesity paradox - Body mass index and outcomes in patients with heart failure [J].
Curtis, JP ;
Selter, JG ;
Wang, YF ;
Rathore, SS ;
Jovin, IS ;
Jadbabaie, F ;
Kosiborod, M ;
Portnay, EL ;
Sokol, SI ;
Bader, F ;
Krumholz, HM .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (01) :55-61
[9]   Body mass and survival in patients with chronic heart failure without cachexia: The importance of obesity [J].
Davos, CH ;
Doehner, W ;
Rauchhaus, M ;
Cicoira, M ;
Francis, DP ;
Coats, AJS ;
Clark, AL ;
Anker, SD .
JOURNAL OF CARDIAC FAILURE, 2003, 9 (01) :29-35
[10]   The obesity paradox in stable chronic heart failure does not persist after matching for indicators of disease severity and confounders [J].
Frankenstein, Lutz ;
Zugck, Christian ;
Nelles, Manfred ;
Schellberg, Dieter ;
Katus, Hugo A. ;
Remppis, B. Andrew .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (12) :1189-1194